Independent Board for Presbyterian Foreign Missions

EMBR LABS APPOINTS NEW STRATEGIC BOARD MEMBERS FOLLOWING SUCCESS OF GLOBAL EXPANSION AND TECHNOLOGICAL ADVANCEMENT

Retrieved on: 
Wednesday, November 1, 2023
Independent Board for Presbyterian Foreign Missions, System, Temperature, Hot, Hunter Boot Ltd, Prostate cancer, HSA, Growth, Marketing, FSA, Sleep, Woman, Corporate development, Johnson & Johnson, Pharmaceutical industry, Embres-et-Castelmaure

In addition to selling direct to consumers, Embr has formed strategic research, marketing, and distribution partnerships with global leaders such as Johnson & Johnson , L'Oréal and Boots in the UK.

Key Points: 
  • In addition to selling direct to consumers, Embr has formed strategic research, marketing, and distribution partnerships with global leaders such as Johnson & Johnson , L'Oréal and Boots in the UK.
  • Sahba has been an advisor to the company for several years, so we are pleased to have her join the board in an official capacity," added Elizabeth Gazda, CEO of Embr Labs.
  • The product is sold directly to consumers on embrlabs.com, as well as in leading retail outlets in the US and UK.
  • Having established successful market traction, Embr is now focused on continuous innovation by deploying hot flash prediction coupled with cooling intervention to prevent hot flashes from occurring.

Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors

Retrieved on: 
Tuesday, October 24, 2023
Government, AdvaMed, State Government Affairs Council, Infection, Health, Central Executive Committee of the Pakistan Peoples Party, Marketing, Executive Committee, DZD, Independent Board for Presbyterian Foreign Missions, Management, Boston Scientific

BOSTON, Oct. 24, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today that independent board member, Jeff Mirviss, has been appointed board chair.

Key Points: 
  • BOSTON, Oct. 24, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today that independent board member, Jeff Mirviss, has been appointed board chair.
  • "Jeff has been an important advisor, investor and supporter of DZD since the early days of our company and the company has benefitted greatly from his involvement and counsel," said Jong Lee, CEO and co-founder, Day Zero Diagnostics.
  • Outside of Boston Scientific, Mr. Mirviss serves on the Executive Board of AdvaMed, the industry association for medtech and diagnostic companies.
  • "I'm honored to be elected chair of the Day Zero Diagnostics Board of Directors and look forward to continuing to work with my colleagues on the Board, as well as the visionary team at DZD," said Jeff Mirviss, chair, DZD Board of Directors.

PeekMed expands into the US with a new subsidiary and a new product

Retrieved on: 
Thursday, October 19, 2023
Independent Board for Presbyterian Foreign Missions, FDA, OEM, X-ray, Surgeon, Elective surgery, News, Research, Multimedia, Artificial intelligence, Growth, CT, Patient satisfaction, Deep learning, Nursing, Orthopedic surgery

WARSAW, Ind., Oct. 19, 2023 /PRNewswire/ -- PeekMed, a provider of orthopedic technology solutions, announced the establishment of PeekMed LLC, its formal subsidiary in Warsaw, Indiana, United States.

Key Points: 
  • WARSAW, Ind., Oct. 19, 2023 /PRNewswire/ -- PeekMed, a provider of orthopedic technology solutions, announced the establishment of PeekMed LLC, its formal subsidiary in Warsaw, Indiana, United States.
  • The decision to form PeekMed LLC is driven by a desire to strengthen presence in the world's largest and most influential healthcare market.
  • This expansion will enable PeekMed to offer versatile solutions and provide timely support to its growing customer base in the US.
  • João Pedro Ribeiro, Co-Founder & CEO of PeekMed, expressed his enthusiasm, stating, "The establishment of PeekMed LLC in the US signifies a pivotal moment in our journey.

Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors

Retrieved on: 
Monday, October 16, 2023
B.A, University of Virginia Darden School of Business, MIT Sloan School of Management, Acquisition, Business, Novartis, Pharmaceutical Research and Manufacturers of America, BMS, PSMA, Medication, Boston Consulting Group, Therapy, Doctor of Philosophy, Gilead Sciences, Biology, Oslo-Fergene, Corporate development, Sutro Biopharma, University, Corporation, Stanford University, Cancer, Bristol Myers Squibb, University of Colorado Student Government, Investment, Senior, Mirati Therapeutics, Wellesley College, TAT, Independent Board for Presbyterian Foreign Missions, Immunology, Mobil, United States of Europe, Canada, Patient, Management, Oncology, Fusion, Ipsen, Microbiology

Dr. Bender, Ms. Bitetti and Mr. Meek succeed Johan Christenson, Ph.D., Chau Khuong and Heather Preston, M.D., who will step down from Fusion's Board effective today.

Key Points: 
  • Dr. Bender, Ms. Bitetti and Mr. Meek succeed Johan Christenson, Ph.D., Chau Khuong and Heather Preston, M.D., who will step down from Fusion's Board effective today.
  • Dr. Jeremy Bender is currently Chief Executive Officer of Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on pediatric cancer.
  • Mr. David Meek most recently served as Chief Executive Officer and Member of the Board of Directors of Mirati Therapeutics.
  • He currently serves on the Board of Directors of uniQure N.V. and previously served on the Board of Directors of Entasis Therapeutics (acquired by Innoviva).

Boyz II Men to Headline the 2023 Executive Leadership Council Annual Recognition Gala in Celebration of Black Business Excellence

Retrieved on: 
Monday, October 2, 2023
The Coca-Cola Company, Corporate America, Investment, Starbucks, Historically black colleges and universities, Repligen Corporation Award in Chemistry of Biological Processes, Ghana UK-Based Achievement Awards, Black, Former, Science, Entertainment Tonight Canada, ELC, Gaylord National Resort & Convention Center, Engineering, STEM, Entertainment Tonight, Convention center, Independent Board for Presbyterian Foreign Missions, Management, University

WASHINGTON, Oct. 2, 2023 /PRNewswire/ -- The Executive Leadership Council (ELC) announced today that 14-time nominated and four-time Grammy award-winning artists Boyz II Men will headline the 2023 Executive Leadership Council Annual Recognition Gala recognizing Black excellence in business and academia. The awards celebration will be hosted by Entertainment Tonight's Kevin Frazier and will take place on Thursday, Oct. 5, 2023 at 6:00 ET, at the Gaylord National Resort and Convention Center, National Harbor, Maryland.

Key Points: 
  • Ariel Investments CEO and Starbucks chairwoman Mellody Hobson to be honored with the 2023 ELC Achievement Award.
  • Independent Board Member and Former Fortune 500 Global Executive, Arlene Isaacs-Lowe will receive the 2023 Alvaro L. Martins Heritage Award.
  • WASHINGTON, Oct. 2, 2023 /PRNewswire/ -- The Executive Leadership Council (ELC) announced today that 14-time nominated and four-time Grammy award-winning artists Boyz II Men will headline the 2023 Executive Leadership Council Annual Recognition Gala recognizing Black excellence in business and academia.
  • Additionally, it hosts a convening of corporate CEOs to discuss the issues that are most impacting Black executives in Corporate America.

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

Retrieved on: 
Tuesday, September 19, 2023
Research, Technology, Infectious Diseases, Stem Cells, Biotechnology, Pharmaceutical, Robotics, Health, Science, Other Science, Cell biology, University of Colorado Colorado Springs, University, Therapy, CSO, RTA, Cancer, Eric Schmidt, Innovation, Antibody, DARPA, Li Ka-shing, Machine learning, Engineering, Cell engineering, SVP, Independent Board for Presbyterian Foreign Missions, Pfizer, Disease, Fine chemical, Vaccine

BioLoomics , the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.

Key Points: 
  • BioLoomics , the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.
  • He founded BioLoomics to apply principles from the RTA project to overcome market-wide throughput limitations for activity-based discovery of antibodies.
  • “Our mission is to make safer, more effective cancer therapeutics by hijacking how human proteins move antibodies around the cell,” said Dr. Douglas Chapnick, founder and CEO of BioLoomics.
  • With this new capital, BioLoomics will develop pre-clinical assets and form strategic partnerships with large pharma companies.

Host Hotels & Resorts Publishes 2023 Corporate Responsibility Report

Retrieved on: 
Monday, September 11, 2023
Workforce, Sustainability Accounting Standards Board, LEED, HST, Howard University, Arne, Woman, Host Hotels & Resorts, DEIB, TCFD, Equity, Independent Board for Presbyterian Foreign Missions, Task Force on Climate Related Financial Disclosures, Trust, Sustainability accounting, Report, Investment, Corporation, Host, CR, DEI, ESG, Environment, Corporate responsibility, Female, Renewable energy, Management

BETHESDA, Md., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, released its 2023 Corporate Responsibility (CR) Report, which details the Company’s CR program and responsible investment strategy along with its environmental, social and governance (ESG) initiatives, performance, progress and industry-leading accomplishments.

Key Points: 
  • BETHESDA, Md., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, released its 2023 Corporate Responsibility (CR) Report, which details the Company’s CR program and responsible investment strategy along with its environmental, social and governance (ESG) initiatives, performance, progress and industry-leading accomplishments.
  • Additionally, the 2023 CR Report introduces the next generation environmental and social performance targets for 2030 that will serve as an interim step to achieving the Company’s aspirational vision of becoming net positive by 2050.
  • “We are proud of our CR program accomplishments this past year as we continued to advance our social and employee-related initiatives and further solidified our position as an industry leader in environmental sustainability,” said Mike Lentz, executive vice president, development, design & construction and executive sponsor of the CR program.
  • “As we transform our 2025 environmental and social targets into business as usual, we are looking forward to focusing our ESG efforts and investments toward achieving our new 2030 goals and targets, which are centered around the most impactful areas of our business and reflect the broader reach and influence of our CR program.

Equinix Appoints Adam Berlew as Chief Marketing Officer

Retrieved on: 
Wednesday, September 6, 2023
Cloud, Boston Consulting Group, University, Dell, Marketing, Telecommunications, Head, Life, Capital G, University of Pennsylvania, MBA, CMO, Equinix, Wharton School of the University of Pennsylvania, Global digital divide, EQIX, Acquisition, Customer, Brown University, Canada Customs and Revenue Agency, Council, Foreign policy, Broadcom Inc., Global marketing, Independent Board for Presbyterian Foreign Missions, Management, Atlassian

REDWOOD CITY, Calif., Sept. 6, 2023 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company®, today announced the appointment of Adam Berlew as Chief Marketing Officer (CMO), effective immediately.

Key Points: 
  • REDWOOD CITY, Calif., Sept. 6, 2023 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company®, today announced the appointment of Adam Berlew as Chief Marketing Officer (CMO), effective immediately.
  • With more than 25 years' experience in strategic marketing and global leadership roles, Berlew returns to Equinix after previously serving as a Vice President of Global Marketing from 2012 to 2015.
  • "We couldn't be more excited to welcome Adam back to Equinix and have him join our leadership team as CMO," said Peter Van Camp, Executive Chairman and interim Chief Revenue Officer, Equinix.
  • Berlew previously served as Head of Global Digital, Enterprise, Economy and Platform Marketing for Atlassian.

AUNA APPOINTS ANASOFIA SANCHEZ JUAREZ TO ITS BOARD OF DIRECTORS

Retrieved on: 
Tuesday, August 29, 2023
Advertising, Risk, International, Monterrey Institute of Technology and Higher Education, Marketing, National University of Singapore, National university, CITY, ITESM, Farallon Capital, World Bank, Institut National d'Optique, McKinsey & Company, Oliver Cromwell, Administration, Bank of America, Partner, Patient, CFO, Sullivan & Cromwell, Commercial, Bank, Health, Secretary of Administration and Finance of Massachusetts, S.A, Grupo Bimbo, UnitedHealth Group, Independent Board for Presbyterian Foreign Missions, INSEEC, Waze, Management, Maestro, Communication

MEXICO CITY and LIMA, Peru, Aug. 29, 2023 /PRNewswire/ -- Auna S.A. ("Auna" or the "Company"), one of the largest players in Latin America's healthcare industry, with presence in Mexico, Colombia and Peru, announced today the appointment of Anasofia Sanchez Juarez to its Board of directors. Ms. Sanchez currently holds the position of Head of Latam at Waze, a community-driven navigation application. Additionally, she serves as a Board member at Grupo Hérdez, one of Mexico's largest food conglomerates, and has recently assumed a role at the Board of directors at Bank of America Mexico, S.A, a subsidiary of Bank of America.

Key Points: 
  • MEXICO CITY and LIMA, Peru, Aug. 29, 2023 /PRNewswire/ -- Auna S.A. ("Auna" or the "Company"), one of the largest players in Latin America's healthcare industry, with presence in Mexico, Colombia and Peru, announced today the appointment of Anasofia Sanchez Juarez to its Board of directors.
  • Mr. Jesus Zamora, Executive Chairman of Auna's Board of Directors and Auna's President, shared his perspective on Ms. Sanchez appointment: "Anasofia is a seasoned sales and marketing leader in the technology sector who brings to Auna an extensive 20-year track record across Mexico and Latin America.
  • Ms. Sanchez, the fourth independent Board member to join Auna's Board of Directors, initiated her career in advertising at agencies TERAN/TBWA, McCann, Ogilvy y Leo Burnett.
  • All independent Board members qualify as such under Rule 10A-3 under the Securities Exchange Act of 1934.

CenterPoint Energy appoints new Independent Board Chair

Retrieved on: 
Tuesday, August 22, 2023
Professional Football Compensation Committee, Audit, CNP, Government, CenterPoint Energy, Biophysical environment, NYSE, Independent Board for Presbyterian Foreign Missions, Management

HOUSTON, Aug. 21, 2023 /PRNewswire/ -- CenterPoint Energy, Inc. (NYSE: CNP) announced that the company's Board of Directors has appointed Earl M. Cummings as its Independent Board Chair. Mr. Cummings has served as an Independent Director of CenterPoint Energy's Board of Directors since 2020. During that time, he has also served as the Chair of the Governance, Environmental and Sustainability Committee, as well as a member of the Audit and Compensation Committees.

Key Points: 
  • HOUSTON, Aug. 21, 2023 /PRNewswire/ -- CenterPoint Energy, Inc. (NYSE: CNP) announced that the company's Board of Directors has appointed Earl M. Cummings as its Independent Board Chair.
  • Mr. Cummings has served as an Independent Director of CenterPoint Energy's Board of Directors since 2020.
  • Mr. Cummings succeeds Martin H. Nesbitt, who served as Independent Board Chair since July 2021.
  • Mr. Cummings said, "I feel privileged to take on the role of Independent Chair of the Board at such an exciting time for our company.